Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Daxor (DXR) Stock Price & Analysis

DXR Stock Chart & Stats

$9.20$0.28(3.14%)
At close: 4:00 PM EDT
$9$10$113 Aug17 Aug31 Aug14 Sep28 Sep12 Oct26 Oct
Day’s Range
$8.40 - $9.20
52-Week Range
$8.40 - $14.76
Previous Close
$8.92
Volume
2,174
Average Volume (3M)
14.61K
Market Cap
$53.71M
Enterprise Value
$45.53M
Total Cash (Recent Filing)
$5.79M
Total Debt (Recent Filing)
$0
Price to Earnings (P/E)
7.5
Beta
0.62
Next Earnings
Mar 10, 2027 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Jan 05, 2018
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Very Low Leverage

Minimal debt and a sizable equity cushion reduce financial strain and leave more flexibility to fund product development, commercialization, and clinical adoption. This stronger balance-sheet position also improves resilience if revenue remains uneven or operating investments take longer to produce returns.

Focused Medical-device Platform

A focused platform addressing blood-volume assessment gives Daxor a clear product identity and a defined clinical use case. If adoption expands among clinicians managing fluid-sensitive cardiovascular conditions, the specialized technology could support a more durable commercial niche over time.

Recent Annual Profitability

Very high operating and net margins in the latest annual period show that the company has demonstrated the ability to report substantial accounting profitability. While the revenue base is volatile, this result provides financial potential that could become more durable if recurring product activity improves.

Bears Say

Severe Revenue Volatility

Sharp swings in revenue make it difficult to establish a dependable growth trajectory or forecast future operating results. The post-spike decline suggests that recent performance has not yet demonstrated repeatable demand, increasing execution risk as Daxor seeks broader clinical adoption.

Inconsistent Cash Generation

Repeated negative operating and free cash flow indicate that reported profitability has not consistently translated into internally generated cash. Continued volatility could constrain investment in commercialization and product development, while increasing reliance on the balance sheet to sustain operations.

Uncertain Earnings Quality

Earnings that depend on irregular items provide weaker evidence of durable operating strength than consistent revenue and margin performance. This uncertainty reduces confidence in forecasting future profits and makes it harder to assess whether recent profitability can persist through the next several quarters.

Daxor News

DXR FAQ

What was Daxor’s price range in the past 12 months?
Daxor lowest stock price was $8.40 and its highest was $14.76 in the past 12 months.
What is Daxor’s market cap?
Daxor’s market cap is $53.71M.
When is Daxor’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Daxor’s earnings last quarter?
Daxor released its earnings results on Aug 20, 2026. The company reported -$0.06 earnings per share for the quarter, missing the consensus estimate of -$0.03 by -$0.03.
Is Daxor overvalued?
According to Wall Street analysts Daxor’s price is currently Undervalued.
Does Daxor pay dividends?
Daxor pays a Monthly dividend of $0.03 which represents an annual dividend yield of ―. See more information on Daxor dividends here
What is Daxor’s EPS estimate?
Daxor’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Daxor have?
Daxor has 5,838,224 shares outstanding.
What happened to Daxor’s price movement after its last earnings report?
Daxor reported an EPS of -$0.06 in its last earnings report, missing expectations of -$0.03. Following the earnings report the stock price went down -2.621%.
Which hedge fund is a major shareholder of Daxor?
Currently, no hedge funds are holding shares in DXR
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology